Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

61. Is Shock Index a Valid Predictor of Mortality in Emergency Department Patients With Hypertension, Diabetes, High Age, or Receipt of beta- or Calcium Channel Blockers?

Is Shock Index a Valid Predictor of Mortality in Emergency Department Patients With Hypertension, Diabetes, High Age, or Receipt of beta- or Calcium Channel Blockers? 26144893 2015 12 28 2016 05 02 2015 12 28 1097-6760 67 1 2016 Jan Annals of emergency medicine Ann Emerg Med Is Shock Index a Valid Predictor of Mortality in Emergency Department Patients With Hypertension, Diabetes, High Age, or Receipt of β- or Calcium Channel Blockers? 106-113.e6 10.1016/j.annemergmed.2015.05.020 S0196-0644(15 (...) )00425-4 Shock index is a widely reported tool to identify patients at risk for circulatory collapse. We hypothesize that old age, diabetes, hypertension, and β- or calcium channel blockers weaken the association between shock index and mortality. This was a cohort study of all first-time emergency department (ED) visits between 1995 and 2011 (n=111,019). We examined whether age 65 years or older, diabetes, hypertension, and use of β- or calcium channel blockers modified the association between shock

EvidenceUpdates2015

62. What are the risks of prescribing both a beta-blocker and a calcium channel blocker?

What are the risks of prescribing both a beta-blocker and a calcium channel blocker? What are the risks of prescribing both a beta-blocker and a calcium channel blocker? Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics What are the risks of prescribing both a beta-blocker and a calcium channel blocker? View/ Open Date (...) 2015-07 Format Metadata Abstract What are the risks of prescribing both a beta-blocker and a calcium channel blocker? Bottom line: When amlodipine or diltiazem are added to beta-blocker therapy for the treatment of stable inducible angina, 0.9% to 4.5% of patients will discontinue therapy due to intolerable dizziness and about 20% of patients will experience cardiovascular adverse events (AEs) (SOR: B, RCTs). About 0.74% of hospital admissions may be due in part to adverse reactions from such drug

Evidence Based Practice 2015

63. Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tam

Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tam Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine

NIHR HTA programme2015

64. Calcium supplementation for prevention of primary hypertension.

Calcium supplementation for prevention of primary hypertension. BACKGROUND: Hypertension is a major public health problem that increases the risk of cardiovascular and kidney diseases. Several studies have shown an inverse association between calcium intake and blood pressure. As small reductions in blood pressure have been shown to produce rapid reductions in vascular disease risk even in individuals with normal blood pressure ranges, this review intends to evaluate the effect of calcium (...) supplementation in normotensive individuals as a preventive health measure. OBJECTIVES: To assess the efficacy and safety of calcium supplementation versus placebo or control for reducing blood pressure in normotensive people. SEARCH METHODS: We searched the Cochrane Hypertension Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, MEDLINE In-Process, EMBASE and ClinicalTrials.gov for randomised controlled trials up to October 2014. The WHO International Clinical

Cochrane2015

65. Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial.

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. 26075752 2015 06 16 2015 08 25 2017 02 20 1539-3704 162 12 2015 Jun 16 Annals of internal medicine Ann. Intern. Med. Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial. 815-24 10.7326/M14-1409 Antiretroviral therapy initiation for HIV-1 infection is associated with 2% to 6% loss of bone mineral density (BMD). To evaluate the effect of vitamin D3 (...) plus calcium supplementation on bone loss associated with antiretroviral therapy initiation. 48-week prospective, randomized, double-blind, placebo-controlled study. (ClinicalTrials.gov: NCT01403051). 39 AIDS Clinical Trials Group units. Adults with antiretroviral therapy-naive HIV. BMD by dual-energy x-ray absorptiometry, 25-hydroxyvitamin D levels, and other laboratory assessments. 165 eligible patients were randomly assigned (79 received vitamin D3 plus calcium and 86 received placebo

Annals of Internal Medicine2015

67. High-Protein Diet Without Increased Calcium Intake Can Lead to Ridge Resorption and Osteoporosis in Women

High-Protein Diet Without Increased Calcium Intake Can Lead to Ridge Resorption and Osteoporosis in Women UTCAT2893, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title High-Protein Diet Without Increased Calcium Intake Can Lead to Ridge Resorption and Osteoporosis in Women Clinical Question How does a high protein diet affect ridge resorption in women? Clinical Bottom Line A high protein diet coupled with a low calcium (...) intake can increase urinary losses of calcium and is linked to osteoporosis and ridge resorption in older women. This is supported by narrative reviews outlining observations of populations who maintain a high protein diet and a narrative review of studies showing the relationship between increased protein intake and increased levels of calcium lost in urine. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence

UTHSCSA Dental School CAT Library2015

68. Additive Prognostic Value of Coronary Artery Calcium Score Over Coronary Computed Tomographic Angiography Stenosis Assessment in Symptomatic Patients Without Known Coronary Artery Disease

Additive Prognostic Value of Coronary Artery Calcium Score Over Coronary Computed Tomographic Angiography Stenosis Assessment in Symptomatic Patients Without Known Coronary Artery Disease 25604930 2015 03 02 2015 05 15 2016 11 25 1879-1913 115 6 2015 Mar 15 The American journal of cardiology Am. J. Cardiol. Additive prognostic value of coronary artery calcium score over coronary computed tomographic angiography stenosis assessment in symptomatic patients without known coronary (...) artery disease. 738-44 10.1016/j.amjcard.2014.12.032 S0002-9149(14)02314-5 The objective of this study was to examine the additive prognostic performance of coronary artery calcium score (CACS) over coronary computed tomography angiography (CCTA) stenosis assessment in symptomatic patients suspected for coronary artery disease (CAD) undergoing CCTA. A total of 805 symptomatic patients without known history of CAD who underwent coronary evaluation by multidetector cardiac CT were analyzed. Mean age of the cohort

EvidenceUpdates2015

69. Oral Calcium Supplementation Does Not Increase Risk of Calcium Nephrolithiasis in Postmenopausal Women

Oral Calcium Supplementation Does Not Increase Risk of Calcium Nephrolithiasis in Postmenopausal Women "Oral Calcium Supplementation Does Not Increase Risk of Calcium Nephrol" by Wei Kuang < > > > > > Title Author Date of Award Summer 8-8-2015 Degree Type Capstone Project Degree Name Master of Science in Physician Assistant Studies First Advisor Mary E. Von, DHEd, PA-C, DFAAPA Second Advisor Annjanette Sommers, PA-C, MS Rights . Abstract Background: The American Association of Clinical (...) Endocrinologists (AACE) current recommendation is 1000-1200 mg calcium daily for postmenopausal and osteoporotic women. Some patients are reluctant to supplement calcium due to the fear of developing a kidney stone (nephrolithiasis). In the United States, every adult will have a 10% to 15% chance to get kidney stones in their lifetime. And the recurrence rate is up to 50% after 10 years. There is no clear theory on how kidney stones are formed. There are lots of factors that play into the role of kidney

Pacific University EBM Capstone Project2015

70. Randomised controlled trial: ?-channel and calcium-channel blockers are ineffective as medical expulsive therapy for ureteral stones regardless of size and location

Randomised controlled trial: ?-channel and calcium-channel blockers are ineffective as medical expulsive therapy for ureteral stones regardless of size and location α-channel and calcium-channel blockers are ineffective as medical expulsive therapy for ureteral stones regardless of size and location | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here α-channel and calcium-channel blockers are ineffective as medical expulsive therapy for ureteral stones regardless of size and location Article Text Therapeutics/Prevention Randomised controlled trial α-channel

Evidence-Based Medicine (Requires free registration)2015

71. Natpara (parathyroid horomone) - To control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism

Natpara (parathyroid horomone) - To control hypocalcemia (low blood calcium levels) in patients with hypoparathyroidism Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Enter Search terms Drug Approval Package - Natpara (parathyroid hormone) Company: NPS Pharmaceuticals Inc. Application No.: 125511 Approval Date: 1/23/2015 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance

FDA - Drug Approval Package2015

72. Vitamin D and calcium: a systematic review of health outcomes (update)

Vitamin D and calcium: a systematic review of health outcomes (update) Vitamin D and calcium: a systematic review of health outcomes (update) Vitamin D and calcium: a systematic review of health outcomes (update) Newberry SJ, Chung M, Shekelle PG, Booth MS, Liu JL, Maher AR, Motala A, Cui M, Perry T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation Newberry SJ, Chung M, Shekelle PG, Booth MS, Liu JL, Maher AR, Motala A, Cui M, Perry T. Vitamin D and calcium: a systematic review of health outcomes (update) Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Report/Technology Assessment No. 217. 2014 Authors' objectives To systematically summarize the evidence on the relationship between vitamin D alone or in combination with calcium on selected health outcomes included in the earlier review: primarily those related

Health Technology Assessment (HTA) Database.2014

75. Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial

Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial 24748637 2014 08 19 2014 10 21 2016 12 15 1468-2044 99 9 2014 Sep Archives of disease in childhood Arch. Dis. Child. Vitamin D treatment in calcium-deficiency rickets: a randomised controlled trial. 807-11 10.1136/archdischild-2013-305275 To determine whether children with calcium-deficiency rickets have a better response to treatment with vitamin D and calcium than with calcium alone. Randomised controlled trial (...) . Jos University Teaching Hospital, Jos, Nigeria. Nigerian children with active rickets treated with calcium carbonate as limestone (approximately 938 mg elemental calcium twice daily) were, in addition, randomised to receive either oral vitamin D2 50,000 IU (Ca+D, n=44) or placebo (Ca, n=28) monthly for 24 weeks. Achievement of a 10-point radiographic severity score ≤1.5 and serum alkaline phosphatase ≤350 U/L. The median (range) age of enrolled children was 46 (15-102) months, and baseline

EvidenceUpdates2014 Full Text: Link to full Text with Trip Pro

76. Fortification of Juices with Calcium Helps Decrease the Risk of Dental Erosion

Fortification of Juices with Calcium Helps Decrease the Risk of Dental Erosion UTCAT2663, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Fortification of Juices with Calcium Helps Decrease the Risk of Dental Erosion Clinical Question In the adult population, does the fortification of calcium to fruit juice reduce enamel erosion as compared to those without calcium? Clinical Bottom Line Results show juices fortified (...) with a calcium compound have the potential to significantly lower the chances of enamel erosion compared to pure juices; however, more evidence is needed to support application clinically. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Scaramucci/2011 80 bovine enamel specimens in various solutions undergoing erosion, demineralization and remineralization. In vitro animal study Key results The specimens

UTHSCSA Dental School CAT Library2014

77. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis

Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis 24366919 2014 09 02 2015 11 02 2017 02 20 1522-9645 35 33 2014 Sep 01 European heart journal Eur. Heart J. Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the Multi-Ethnic Study of Atherosclerosis. 2232-41 10.1093/eurheartj/eht508 We (...) sought to evaluate the impact of coronary artery calcium (CAC) in individuals at the extremes of risk factor (RF) burden. 6698 individuals from the Multi-Ethnic Study of Atherosclerosis (MESA) were followed for coronary heart disease (CHD) events over mean 7.1 ± 1 years. Annualized CHD event rates were compared among each RF category (0, 1, 2, or ≥3) after stratification by CAC score (0, 1-100, 101-300, and >300). The following traditional modifiable RFs were considered: cigarette smoking

EvidenceUpdates2014

79. Cohort study: Calcium supplements associated with increased risk of cardiovascular death in men but not women

Cohort study: Calcium supplements associated with increased risk of cardiovascular death in men but not women Calcium supplements associated with increased risk of cardiovascular death in men but not women | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium supplements associated with increased risk of cardiovascular death in men but not women Article Text Primary health care Cohort study Calcium supplements associated with increased risk of cardiovascular death in men but not women Mark J Bolland , Andrew Grey Statistics from Altmetric.com

Evidence-Based Nursing (Requires free registration)2014

80. Cohort study: Daily calcium intake in excess of 1400?mg is associated with increased all-cause and cardiovascular disease mortality in women

Cohort study: Daily calcium intake in excess of 1400?mg is associated with increased all-cause and cardiovascular disease mortality in women Daily calcium intake in excess of 1400 mg is associated with increased all-cause and cardiovascular disease mortality in women | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily calcium intake in excess of 1400 mg is associated with increased all-cause and cardiovascular disease mortality in women Article Text Primary healthcare Cohort study Daily calcium intake in excess of 1400 mg is associated with increased all

Evidence-Based Nursing (Requires free registration)2014